TOPLINE: Higher baseline expression of interferon (IFN)-driven genes was tied to a better response to methotrexate in patients with juvenile idiopathic arthritis (JIA). METHODOLOGY: Analysis of the link between blood biomarkers and response to methotrexate …
Background Chronic obstructive pulmonary disease (COPD) is a chronic inflammatory disease of the lungs caused by progressive obstruction of the airways because of smoking and inhalation of particulate matter.1 The incidence rate of COPD has continued to …
Introductions Severe pneumonia is a common acute and critical disease in clinical practice, characterized by acute onset, rapid progression, multiple complications and high mortality rate. It is a major disease threatening human life and health worldwide. …
Current tuberculosis infection tests struggle to detect the disease in those with HIV. A common co-infection, HIV can hide TB from traditional tests by eliminating the immune cells relied upon to sound the alarm. While more than 90% of the 2 billion TB …
Video content above is prompted by the following: The clinical evidence supporting PIRA as a legitimate concept in MS management is substantial and growing. Key landmark studies have validated PIRA’s role in disability progression, starting with the …
(MENAFN- PR Newswire) Approval based on the pooled analysis of our pivotal EMERALD and NI-0501-06 studies, showing 54% of patients treated with Gamifant achieved complete response at week 8. STOCKHOLM, June 28, 2025 /PRNewswire/ -- Sobi® (STO: SOBI …
Register for free to listen to this article Thank you. Listen to this article using the player above. ✖ Want to listen to this article for FREE? Complete the form below to unlock access to ALL audio articles. A portable diagnostic device that uses a beetle …
Macro shot of a bombardier beetle on leaf. [seanjoh/ iStock / Getty Images Plus] When threatened, the bombardier beetle launches a noxious chemical spray by combining two compounds in its abdomen—a natural defense mechanism that doesn’t require …
In a groundbreaking advancement that could reshape cancer immunotherapy, researchers from Van Andel Institute and collaborators have identified a novel immune checkpoint target called PTGIR, a prostacyclin receptor intricately involved in regulating CD8+ T …
&
